GALT
Galectin Therapeutics Inc.
NASDAQ · USHealthcareBiotechnology
$4.00-4.19%
Price as of Jul 20, 2026
GALT earnings
Galectin Therapeutics Inc. earnings
Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.
Next earnings
Aug 13, 2026in NaN days
EPS est $-0.09 · Revenue est —
Track record
Beat EPS in 7 of 12 quarters
Avg surprise -1.6% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 15, 2026 | $-0.06 | $-0.08 | -33.3% | — | — |
| Mar 31, 2026 | $-0.10 | $-0.08 | +20.0% | — | — |
| Nov 14, 2025 | $-0.11 | $-0.13 | -18.2% | — | — |
| Aug 14, 2025 | $-0.16 | $-0.12 | +25.0% | — | — |
| May 15, 2025 | $-0.20 | $-0.15 | +25.0% | — | — |
| Mar 31, 2025 | $-0.16 | $-0.19 | -18.8% | $36000 | — |
| Nov 14, 2024 | $-0.20 | $-0.18 | +10.0% | — | — |
| May 15, 2024 | $-0.16 | $-0.19 | -18.8% | — | — |
| Mar 29, 2024 | $-0.16 | $-0.16 | +0.0% | $80000 | — |
| Aug 14, 2023 | $-0.21 | $-0.15 | +28.6% | — | — |
| May 15, 2023 | $-0.21 | $-0.19 | +9.5% | — | — |
| Nov 14, 2022 | $-0.20 | $-0.14 | +30.0% | — | — |
Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-13.